Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-21

Clinical Trial Update: Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares intranasal sufentanil with intravenous morphine for acute pain management. The current status in ClinicalTrials.gov is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Sufentanil (sufentanil)

Snippet

Sponsor: The Brooklyn Hospital Center | Conditions: Acute Pain | Phase 4 | Status: UNKNOWN